Catálogo de publicaciones - libros
Título de Acceso Abierto
In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
nanoparticle; multimodal imaging; photoacoustic; heterobivalent peptide; Alzheimer’s disease; amyloid-beta; animal model; astrocyte; blood–brain barrier; imaging; metabolism; microglia; neuroinflammation; neurotransmitter receptors; positron emission tomography; synaptic density; vascular imaging; FDG; PET/CT; microvasculature imaging; ABC-transporter; drug-induced liver injury; hepatotoxicity; organic anion-transporting polypeptide; pharmacokinetics; liver function; SLC-transporter; V/Q PET/CT; [68Ga]Ga-MAA; 68Ga-labelled carbon nanoparticles; glioblastoma; fluorescence guided surgery; 5-ALA; fluorescein; NIR-AZA; magnetic resonance imaging; high resolution; hybrid imaging; psychiatric disorders; extracellular vesicles (EVs); umbilical cord mesenchymal stem cell (UCMSC); diabetes; I-124; positron emission tomography (PET); intravenous (I.V.) administration; intra-arterial (I.A.) administration; biodistribution; fluorine-18; PET; oxime; PSMA; lipophilicity; radiometals; copper-61; liquid targets; post-processing; [61Cu]Cu-DOTA-NOC; [61Cu]Cu-DOTA-TOC; [61Cu]Cu-DOTA-TATE; FAP; 99mTc-FAP inhibitor; 99mTc-labeled iFAP; tumor microenvironment; SPECT; GluN1/2B receptors; NMDA; [3H]ifenprodil; σ1 and σ2 receptors; receptor occupancy; PET imaging; drug development; neurodegenerative diseases; n/a
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No requiere | Directory of Open access Books |
Información
Tipo de recurso:
libros
País de edición
Suiza